AVMA news
Drugs treating epilepsy, feline diabetes receive FDA approval
The Food and Drug Administration (FDA) has recently approved a number of animal drugs, including those that treat idiopathic epilepsy in dogs and…
AVMA news
Four veterinary scientists recognized with AVMA research awards
The AVMA honored Drs. Jim E. Riviere, Nicholas (Nick) Jeffery, Natasha Olby, and Boaz Arzi with 2023 AVMA Excellence Awards for contributions to…
JAVMA news
Groups issue warnings on improper vaccine use
Practitioners must always walk a fine line when deciding how to tailor vaccine protocols for their patients, but a certain activity has drawn the…
AVMA news
New listings in AVMA Animal Health Studies Database – May 2023
The latest list of veterinary clinical studies in the AVMA Animal Health Studies Database (AAHSD) are available, including a study evaluating the…
AVMA news
AAHA publishes allergic skin disease guidelines for dogs, cats
On October 31, the American Animal Hospital Association (AAHA) announced the publication of the 2023 AAHA Management of Allergic Skin Diseases in Dogs…
AVMA news
FDA approves anemia drug for cats with chronic kidney disease
Varenzin-CA1 from Elanco is the first drug for the control of nonregenerative anemia associated with chronic kidney disease in cats to receive…
AVMA news
Generic drugs for treating inflammation, vomiting, parasites receive FDA approval
The Food and Drug Administration announced in March and April that it had approved six generic animal drugs.